ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 40

$615K Total Retail Price of All Prescriptions

Rank: 1 out of 40

228 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alaska
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 228 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

53% of this provider’s 228 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,500 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alaska
SIMVASTATIN 508 468 1 3
METFORMIN HCL 388 351 2 7
OMEPRAZOLE 356 329 3 6
HYDROCODONE-ACETAMINOPHEN 347 204 S3 4 4
ALENDRONATE SODIUM 263 251 5 10
AMLODIPINE BESYLATE 259 225 6 5
LIDODERM 252 247 7 22
CRESTOR 240 226 8 20
RANITIDINE HCL 229 188 9 27
RAMIPRIL 197 190 10 25
LEVOTHYROXINE SODIUM 182 155 11 8
NEXIUM 177 156 12 13
GLIPIZIDE 168 155 13 32
LOVAZA 152 132 14 37
LISINOPRIL 150 126 15 1
DIOVAN HCT 140 133 16 33
TAMSULOSIN HCL 137 134 17 21
ATORVASTATIN CALCIUM 137 135 17 15
METOPROLOL SUCCINATE 128 115 19 9
GLIPIZIDE ER 124 119 20 52
ZOLPIDEM TARTRATE 118 102 21 26
FUROSEMIDE 111 99 22 2
DIOVAN 109 104 23 14
HYDROCHLOROTHIAZIDE 101 81 24 17
ACETAMINOPHEN-CODEINE 93 79 S3 25 67
METOPROLOL TARTRATE 82 63 26 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 49 27 72
NAMENDA 77 77 28 28
IPRATROPIUM BROMIDE 75 68 29 74
SYNTHROID 74 63 30 29
TRICOR 73 62 31 43
AZITHROMYCIN 73 62 31 76
LOSARTAN POTASSIUM 72 67 33 16
GLIPIZIDE XL 70 70 34 79
TRILIPIX 63 63 35 86
FLUOXETINE HCL 62 57 36 89
SPIRIVA 61 54 37 92
ADVAIR DISKUS 60 57 38 93
PEN NEEDLE 60 47 38 54
TRIAMTERENE-HCTZ 59 57 40 94
OXYCODONE-ACETAMINOPHEN 59 39 S2 40 94
CARVEDILOL 54 40 42 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.